Stroke study: HandMate
Official title Hand Exoskeleton Training Study
ClinicalTrials.gov ID: NCT06786858
What this study is testing
- What it's testing
- The goal of this study is to look at the HandMATE device's effectiveness in the rehabilitation of stroke patients and asses if the HandMATE application is received well by stroke survivors.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Age of 21 or older
- diagnosis of stroke more than 6 months prior confirmed from MRI or CT
- voluntary hand activity (score of 1 or more, finger extension item, Fugl-Meyer Test)
- adequate cognitive status
- Impaired ability to open affected hand
You likely can't join if
- hemispatial neglect
- severe sensory loss (2 or more on the sensory item, NIH Stroke Scale/Score)
- receiving or planning to receive antispasticity medications during enrollment into the study
- less than full passive range of motion in finger joints
- receiving physical or occupational therapy outside of study protocols
- have excessive pain in any joint of the affected extremity that could limit ability to cooperate with the protocols
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.